Hemorrhagic Pituitary Apoplexy in Pregnancy: What's True?

Poll

Brain scans in a pregnant woman who had been undergoing evaluation for a pituitary adenoma revealed a hemorrhagic pituitary macroadenoma.

Brain scans in a pregnant woman who had been undergoing evaluation for a pituitary adenoma revealed a hemorrhagic pituitary macroadenoma.

Which of the following statements about pituitary tumor apoplexy is true?

A) The trigger is sudden vascular compromise of the pituitary related to hemorrhage or infarction.
B) Sequelae result from pressure from acute enlargement of an adenomatous pituitary.
C) Less commonly, sequelae result from a non-adenomatous pituitary.
D) Predisposing factors include endocrine stimulation tests and pregnancy.
E) Conservative management is usual in patients with mild stable signs or who present subacutely.
F) Visual compromise from elevated intracranial pressure is a primary acute complication.
G) All of the above are true.
Recent Videos
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Optimizing Diabetes Therapies with New Classifications
Should We Reclassify Diabetes Subtypes?
Roger S. McIntyre, MD: GLP-1 Agonists for Psychiatry?
Daniel Gaudet, MD, PhD | Credit: American College of Cardiology
Related Content
Alie Rezaie, MD | Credit: Cedars-Sinai

Surge in New GLP-1 Prescriptions Driven by Semaglutide's Popularity, Study Shows

Patrick Campbell
July 22nd 2024
Article
John Buse, MD, PhD | Credit: UNC School of Medicine

Diabetes Dialogue: CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 15th 2024
Podcast
FDA Issues CRL to Once-Weekly Insulin Icodec | Image Credit: US Food and Drug Administration

FDA Issues Complete Response Letter for Once-Weekly Insulin Icodec

Connor Iapoce
July 11th 2024
Article
Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 3rd 2024
Podcast
Nicholas Stucky, MD, PhD | Credit: LinkedIn

Tirzepatide Bests Semaglutide in Real-World Weight Loss Analysis

Patrick Campbell
July 8th 2024
Article
HCPLive Endocrinology Month In Review June 2024 Thumbnail

Endocrinology Month in Review: June 2024

Patrick Campbell
July 5th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.